Malvern, PANalytical to Merge
Malvern and PANalytical are pleased to announce that effective 1 January 2017 they will be merging their activities. Both companies are owned by parent company Spectris plc and are operating companies within the Materials Analysis segment of Spectris.
Both companies are world leading suppliers of analytical instrumentation, PANalytical for X-ray instrumentation and software for the purpose of materials analysis and Malvern Instruments for materials and biophysical characterization technology. The combined entity is a strong player in the materials characterization market and will be able to leverage the strengths of the individual companies in their end markets ranging from building materials to pharmaceuticals and from metals and mining to nanomaterials. .
The merger is based on the belief that there are clear benefits through this more collaborative relationship, leveraging the very strong brands and highly-skilled employees of the two companies, in order to deliver a more complete range of products, solutions and services to a broader set of markets and customers.
The companies will be working together to ensure a smooth and effective integration guaranteeing our usual high level of support to all our customers. The combined group will continue to develop and invest in the Malvern and PANalytical technologies and the highly-talented workforce.
Eoghan O’Lionaird, Business Group Director responsible for the Materials Analysis segment within Spectris, says: “This is an exciting time for Malvern and PANalytical. Joining the two companies will enable us to leverage new resources to further grow our service offering and add even more value to our clients and customers. We are committed to ensuring a smooth integration process and will be actively engaging with our customers on how the combined entity can better serve their needs.”
Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.
Simple Water Test Could Prevent Crippling Bone DiseaseNews
A simple colour-changing test to detect fluoride in drinking water, could in the future prevent the crippling bone disease, skeletal fluorosis, in developing countries such as India and Tanzania.READ MORE
Allergy Amplifier Implicated in Asthma Also Intensifies Food AllergyNews
Scientist who previously reported that a small protein, aptly named histamine-releasing factor, played a pro-inflammatory role in asthma have now shown that it also serves as a “food allergy amplifier”. This work paves the way for blood tests to predict which patients will respond to allergy therapy, and strongly supports the idea that drugs designed to block HRF could prevent food allergy attacks.READ MORE
Higher Diabetes Rates in Minorities May be Driven By Environmental PollutantsNews
Unequal exposure to environmental pollutants acting as endocrine-disrupting chemicals is an under-recognized risk factor that may play a key role in driving the higher rates of diabetes among minority and low-income populations.READ MORE